Carlos Vay
Overview
Explore the profile of Carlos Vay including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
112
Citations
808
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Montalvo E, Veiga F, Rodriguez H, Traglia G, Vay C, Almuzara M
Rev Argent Microbiol
. 2024 Dec;
PMID: 39710531
Aeromonas spp. are opportunistic pathogens that cause both intra- and extraintestinal infections. The objective of this work was the phenotypic and genotypic characterization of a collection of Aeromonas strains, in...
2.
Alvarez C, Nastro M, Goyheneche B, Potente N, Ledesma M, Vay C, et al.
J Antimicrob Chemother
. 2024 Sep;
79(12):3174-3177.
PMID: 39310949
Background: A drastic increase in carbapenem resistance among Klebsiella pneumoniae isolates occurred during the period 2019-22. Three epidemiological changes could be evidenced: (i) NDM became the predominant carbapenemase; (ii) NDM-5...
3.
Barberis C, Traglia G, Haim M, Poklepovich T, De Belder D, Arrieta R, et al.
Diagn Microbiol Infect Dis
. 2024 Aug;
110(2):116476.
PMID: 39111106
We present a case of a 34-year-old patient with abdominal sepsis caused by an infrequent species: Chimaeribacter arupi. Genomic analysis confirmed the identification which is difficult to achieve by other...
4.
Almuzara M, Cittadini R, Traglia G, Haim M, De Belder D, Alvarez C, et al.
Infect Prev Pract
. 2024 Jul;
6(3):100379.
PMID: 39006243
Members of the genus (order ) are isolated from the natural environment and clinical settings. Identification of strains based on biochemical characteristics is complicated due to taxonomic confusion, and they...
5.
Traglia G, Furtado N, Escalante J, Almuzara M, Cittadini R, Tuttobene M, et al.
Int J Antimicrob Agents
. 2024 May;
64(2):107218.
PMID: 38815701
No abstract available.
6.
de Oliveira SantAnna L, Dos Santos L, Olivella J, da Cruz Mota M, Ramos J, Baio P, et al.
Braz J Microbiol
. 2024 Apr;
55(2):1405-1414.
PMID: 38598149
Background: Corynebacterium spp. are widely disseminated in the environment, and they are part of the skin and mucosal microbiota of animals and humans. Reports of human infections by Corynebacterium spp....
7.
Costa A, Figueroa-Espinosa R, Martinez J, Fernandez-Canigia L, Maldonado M, Bergese S, et al.
Pathogens
. 2023 Jul;
12(7).
PMID: 37513712
Carbapenemase resistance in is a global public health problem and rapid and effective methods for detecting these resistance mechanisms are needed urgently. Our aim was to evaluate the performance of...
8.
Mariani F, Juarez G, Barberis C, Veiga F, Vay C, Galvan E
Biofouling
. 2023 Jul;
39(5):579-590.
PMID: 37482939
Diabetic foot ulcers (DFU) are exacerbated by bacterial colonisation. Here, a high prevalence of was observed in DFU patients from an Argentinean hospital. was frequently co-isolated with , , and...
9.
Vega J, Rodriguez C, Viscardi I, Vay C, Torres S, Tabares E, et al.
Rev Argent Microbiol
. 2023 Apr;
55(3):251-254.
PMID: 37100682
Carbapenemase-producing-Serratia marcescens isolates, although infrequent, are considered important nosocomial pathogens due to their intrinsic resistance to polymyxins, which limits therapeutic options. We describe a nosocomial outbreak of SME-4-producing S. marcescens...
10.
Ledesma M, Poodts D, Amoia S, Hajos S, Fundia A, Vay C, et al.
Sci Rep
. 2023 Apr;
13(1):5596.
PMID: 37019937
Chemotherapy mistreatment is partially due to a lack of rapid and reliable tools to discriminate between sensitive and resistant phenotypes. In many cases, the resistance mechanism is not fully understood,...